Trials / Completed
CompletedNCT04422314
ImmuneSense Lyme Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 893 (actual)
- Sponsor
- Adaptive Biotechnologies · Industry
- Sex
- All
- Age
- 7 Years
- Healthy volunteers
- —
Summary
ImmuneSense Lyme is a study, which is designed to better understand the immune response to Lyme disease. This is critically important because the immune system may be able to tell us important information about how our own bodies detect and respond to the disease that current tests cannot. Data collected from this study may accelerate the development of better diagnostics for Lyme disease and improve outcomes for many.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | T-Detect Lyme | T-Detect Lyme is an investigational use test that uses multiplex PCR and NGS to assess rearranged T-cell receptor beta (TRB) gene sequences from genomic DNA isolated from human peripheral blood. |
Timeline
- Start date
- 2020-07-09
- Primary completion
- 2021-10-29
- Completion
- 2021-10-30
- First posted
- 2020-06-09
- Last updated
- 2022-04-15
Locations
34 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04422314. Inclusion in this directory is not an endorsement.